STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — SpringWorks Therapeutics Inc. (SWTX) on Wednesday reported a loss of $39.9 million in its second quarter.

On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 54 cents.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.12 per share.

The biopharmaceutical company posted revenue of $59.7 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $34.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SWTX at https://www.zacks.com/ap/SWTX